Indeed it does look like India is the first to say Remdesivir is not worth using. It doesn't provide benefit in terms of mortality, and it MAY reduce the length of hospital stay -- but not according to some newer studies.

In the video they mention that overuse of steroids is contributing to the horrible black fungus infections that patients there are getting.

An actual anti-viral is needed. I hope that there will be positive Brilacidin results soon enough to help people, especially in places where the virus is raging out of control and with insuffifcient medical facilities -- India, Brazil, Nepal, among others.